These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The prevention of haemolytic disease of the newborn. Mellon DE Ir J Med Sci; 1967 Jun; 6(498):276-80. PubMed ID: 6069026 [No Abstract] [Full Text] [Related]
6. Haemolytic disease of the newborn: the new NICE guidelines. Thompson J J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064 [TBL] [Abstract][Full Text] [Related]
7. [Intensive plasma exchange for the prevention of hemolytic disease of the newborn caused by anti-Rhesus alloimmunization]. Dupont E; Lambermont M; Thayse C; Gammar N; Vanherweghem JL; Rodesh F; Schwers J; Wybran J Rev Med Brux; 1983 Dec; 4(10):663-6. PubMed ID: 6658250 [No Abstract] [Full Text] [Related]
8. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease. Craig JS; McClure BG; Tubman TR BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034 [No Abstract] [Full Text] [Related]
9. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland. Craig S; Morris K; Tubman T; McClure B Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367 [TBL] [Abstract][Full Text] [Related]
10. [Rhesus prevention and course following amniocentesis in early pregnancy]. Herrmann U; Sidiropoulos D Gynakol Rundsch; 1983; 23(3):153-9. PubMed ID: 6605902 [No Abstract] [Full Text] [Related]
11. [Mode of action of immunoprevention in anti-Rh-induced haemolytic disease of newborn infants]. Schubert W; Tesar V Dtsch Gesundheitsw; 1972 Nov; 27(47):2243-5. PubMed ID: 4662688 [No Abstract] [Full Text] [Related]
12. Prevention of haemolytic disease of the newborn by the administration of anti-D to the mother. Ger Med Mon; 1969 Feb; 14(2):58-62. PubMed ID: 5781984 [No Abstract] [Full Text] [Related]
13. Rh haemolytic disease of the newborn: the role of the laboratory. Tovey LA Med Lab Sci; 1982 Jul; 39(3):297-303. PubMed ID: 6813628 [No Abstract] [Full Text] [Related]
14. Prevention of Rh-haemolytic disease. Clarke CA Br Med J; 1968 Jan; 1(5583):57-8. PubMed ID: 5636752 [No Abstract] [Full Text] [Related]
15. [On the passage of fetal erythrocytes into the maternal circulation and prevention of perinatal hemolytic disease]. Botella LlusiĆ” J An R Acad Nac Med (Madr); 1966; 83(2):159-67. PubMed ID: 5952983 [No Abstract] [Full Text] [Related]
16. [Current trends in the prevention and therapy of hemolytic disease in the fetus and newborn infant. Review note]. Marsico S Arch Ostet Ginecol; 1965; 70(6):508-30. PubMed ID: 5327174 [No Abstract] [Full Text] [Related]
17. [Problems of Rhesus prophylaxis]. Baumgarten K Med Lab (Stuttg); 1982 Oct; 35(4):115-21. PubMed ID: 6185833 [No Abstract] [Full Text] [Related]
18. Rhesus haemolytic disease of the newborn, complicating a quadruplet pregnancy. Elasoud K; McClure G; Halliday HL; Dornan JC Ulster Med J; 1997 May; 66(1):62-4. PubMed ID: 9185494 [No Abstract] [Full Text] [Related]
19. [20 years treatment of rhesus antagonism]. Cremers HP Ned Tijdschr Verloskd Gynaecol; 1970 Apr; 70(2):97-109. PubMed ID: 5438893 [No Abstract] [Full Text] [Related]
20. Prevention of rhesus (D) immunisation--some causes of failure in Northern Ireland. McClelland WM; McLoughlin KG Ulster Med J; 1980; 49(2):148-52. PubMed ID: 6777935 [No Abstract] [Full Text] [Related] [Next] [New Search]